Recruiting
Checkpoint Inhibitor-induced Liver Injury
NCT04476563
- Conditions
- Immune-mediated Hepatitis
- Locations
-
- University of Nottingham Nottingham, United Kingdom
Clinical trial condition
Immune-mediated Hepatitis
Explore clinical trials studying Immune-mediated Hepatitis. Study availability and eligibility vary by location and protocol.
5 public trials
4 recruiting studies
Immune-mediated Hepatitis trial results
Recruiting
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997
- Conditions
- Immune-mediated Hepatitis
- Locations
-
- CHU de Montpellier Montpellier, France
Recruiting
Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
NCT07167251
- Conditions
- Cancer, Immune Related Adverse Events, Immune-mediated Hepatitis, +1 more
- Locations
-
- University Hospital Basel Basel, Canton of Basel-City, Switzerland
- Royal Marsden Hospital London, United Kingdom
NCT05484908
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Not Yet Recruiting
Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy
NCT07663422
- Conditions
- Immune-mediated Hepatitis, Immune-related Adverse Event
- Locations
-
Not specified